Literature DB >> 21804527

Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation.

Ozgur Mete1, Sylvia L Asa.   

Abstract

There are many controversies involving the diagnostic criteria and treatment of well-differentiated thyroid carcinoma. Vascular invasion has been identified as an important and independent prognosticator in many cancers. The majority of pathologists recognize the importance of vascular invasion as a diagnostic marker of malignancy in follicular lesions of thyroid; however, several reports have suggested that angioinvasion is not a predictor of bad prognosis in thyroid carcinomas. We suggest that the criteria for diagnosing angioinvasion in thyroid carcinomas as well as in other endocrine tumors are inconsistent and the controversy may be attributed to application of inappropriate criteria. We carried out a study of a potential cause of artefactual vascular invasion in a series of autopsy thyroids and established the morphology of mimics of angioinvasion. We then reviewed retrospectively the clinicopathological features of a series of 4000 thyroid carcinomas of follicular epithelial derivation to identify the features and significance of the most rigid criteria of vascular invasion: tumor cells invading through a vessel wall and thrombus adherent to intravascular tumor. These features were identified in 118 (3%) lesions. Follow-up information was available for 98 patients. Of these, 35% developed distant metastases. When using the rigid criteria, ∼1/3 of angioinvasive well-differentiated thyroid carcinomas and 1/2 of angioinvasive poorly differentiated thyroid carcinomas developed distant metastases at a mean 5.3 years of follow-up. Our results indicate that the application of rigid criteria for vascular invasion provide a clinically relevant prediction of distant metastasis in patients with thyroid carcinomas, especially in well-differentiated thyroid carcinomas.

Entities:  

Mesh:

Year:  2011        PMID: 21804527     DOI: 10.1038/modpathol.2011.119

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  47 in total

1.  The Clinical Significance of Lymphovascular Invasion in Gastric Cancer.

Authors:  Hirohito Fujikawa; Keisuke Koumori; Hayato Watanabe; Kazuki Kano; Yyta Shimoda; Toru Aoyama; Takanobu Yamada; Tamagawa Hiroshi; Naoto Yamamoto; Haruhiko Cho; Manabu Shiozawa; Takaki Yoshikawa; Souichiro Morinaga; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Takashi Oshima
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Encapsulated Thyroid Carcinoma of Follicular Cell Origin.

Authors:  Bin Xu; Ronald Ghossein
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

3.  Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases.

Authors:  Massimo Bongiovanni; Silvia Uccella; Luca Giovanella; Francesca Molinari; Milo Frattini; Gianlorenzo Dionigi; Eliana Piantanida; Antoine Nobile; Fausto Sessa; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

4.  Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.

Authors:  Krzysztof Glomski; Vania Nosé; William C Faquin; Peter M Sadow
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

Review 5.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

6.  Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model.

Authors:  Elizabeth M Peek; David R Li; Hanwei Zhang; Hyun Pyo Kim; Baohui Zhang; Isla P Garraway; Arnold I Chin
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

8.  Villous papillary thyroid carcinoma: a variant associated with marfan syndrome.

Authors:  Daniel A Winer; Shawn Winer; Lorne Rotstein; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

9.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

10.  Prognostic and predictive markers in medullary thyroid carcinoma.

Authors:  Boban M Erovic; Dae Kim; Clarissa Cassol; David P Goldstein; Jonathan C Irish; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.